Transcode Therapeutics, Inc. (RNAZ) KPIs and segments

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$1.32−0.07 (-5.06%)

Close on Nov 13, 2026Market cap $1.34MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Transcode Therapeutics's business

Coming soon

This tab will track the numbers specific to Transcode Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?